Search research articles
Contact Us
Filters
Showing results (11-20 of 65) with videos related to
Page
of 7
Sort By:
Histopathology
|
October 22, 2024
Data set for the reporting of lung cancer: recommendations from the International Collaboration on Cancer Reporting (ICCR)
Wendy A Cooper, Fleur Webster, Kelly J Butnor, et al.
NPJ Precision Oncology
|
November 20, 2025
MET (c-Met) protein overexpression is an emerging protein biomarker in non-small cell lung cancer
Ming-Sound Tsao, Lynette Sholl, Michelle Shiller, et al.
JHLT Open
|
March 27, 2025
Radiological distribution patterns in restrictive chronic lung allograft dysfunction: Impact on survival across all phenotypes
Taiki Fukuda, Yusei Nakamura, Shu-Chi Tseng, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 25, 2022
Concurrent TP53 Mutations Facilitate Resistance Evolution in EGFR-Mutant Lung Adenocarcinoma
Natalie I Vokes, Emily Chambers, Tom Nguyen, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 27, 2019
B Cell-Adaptive Immune Profile in Emphysema-Predominant Chronic Obstructive Pulmonary Disease
John-Lawrence Sullivan, Bhavani Bagevalu, Carolyn Glass, et al.
JCO Precision Oncology
|
June 11, 2025
Efficacy and Safety of Tarlatamab in a Patient With Advanced Delta-Like Ligand 3-Positive Large Cell Neuroendocrine Lung Carcinoma and Untreated Brain Metastases: A Case Report
Eleonora Gariazzo, Sanna Laaksonen, Stephanie Canty, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
May 6, 2025
Lung cancer recurrence after neoadjuvant immunotherapy
Hao Li, Fatemehsadat Pezeshkian, Yue Xie, et al.
Journal of the American Medical Informatics Association : JAMIA
|
January 10, 2018
Interactive or static reports to guide clinical interpretation of cancer genomics
Stacy W Gray, Jeffrey Gagan, Ethan Cerami, et al.
JCO Precision Oncology
|
October 7, 2024
Response to Crizotinib After Entrectinib Resistance in <i>ROS1</i>-Rearranged, <i>MET</i>-Amplified Lung Adenocarcinoma
Victor R Vaz, Malini M Gandhi, Biagio Ricciuti, et al.
Journal for Immunotherapy of Cancer
|
December 21, 2025
Multi-omics analysis reveals differential benefits of immunotherapy±chemotherapy based on detailed smoking history in advanced non-small cell lung cancer
Xinan Wang, Biagio Ricciuti, Arielle Elkrief, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 65) with videos related to
Sort By:
Page
of 7
Histopathology
|
October 22, 2024
Data set for the reporting of lung cancer: recommendations from the International Collaboration on Cancer Reporting (ICCR)
Wendy A Cooper, Fleur Webster, Kelly J Butnor, et al.
NPJ Precision Oncology
|
November 20, 2025
MET (c-Met) protein overexpression is an emerging protein biomarker in non-small cell lung cancer
Ming-Sound Tsao, Lynette Sholl, Michelle Shiller, et al.
JHLT Open
|
March 27, 2025
Radiological distribution patterns in restrictive chronic lung allograft dysfunction: Impact on survival across all phenotypes
Taiki Fukuda, Yusei Nakamura, Shu-Chi Tseng, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 25, 2022
Concurrent TP53 Mutations Facilitate Resistance Evolution in EGFR-Mutant Lung Adenocarcinoma
Natalie I Vokes, Emily Chambers, Tom Nguyen, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 27, 2019
B Cell-Adaptive Immune Profile in Emphysema-Predominant Chronic Obstructive Pulmonary Disease
John-Lawrence Sullivan, Bhavani Bagevalu, Carolyn Glass, et al.
JCO Precision Oncology
|
June 11, 2025
Efficacy and Safety of Tarlatamab in a Patient With Advanced Delta-Like Ligand 3-Positive Large Cell Neuroendocrine Lung Carcinoma and Untreated Brain Metastases: A Case Report
Eleonora Gariazzo, Sanna Laaksonen, Stephanie Canty, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
May 6, 2025
Lung cancer recurrence after neoadjuvant immunotherapy
Hao Li, Fatemehsadat Pezeshkian, Yue Xie, et al.
Journal of the American Medical Informatics Association : JAMIA
|
January 10, 2018
Interactive or static reports to guide clinical interpretation of cancer genomics
Stacy W Gray, Jeffrey Gagan, Ethan Cerami, et al.
JCO Precision Oncology
|
October 7, 2024
Response to Crizotinib After Entrectinib Resistance in <i>ROS1</i>-Rearranged, <i>MET</i>-Amplified Lung Adenocarcinoma
Victor R Vaz, Malini M Gandhi, Biagio Ricciuti, et al.
Journal for Immunotherapy of Cancer
|
December 21, 2025
Multi-omics analysis reveals differential benefits of immunotherapy±chemotherapy based on detailed smoking history in advanced non-small cell lung cancer
Xinan Wang, Biagio Ricciuti, Arielle Elkrief, et al.
Page
of 7